The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3579-3585

  Vaisman, Alexandra ^a   Varchenko, Maria ^a   Umar, Asad ^b   Kunkel, Thomas A ^b   Risinger, John I ^b   Barrett, J Carl ^b   Hamilton, Thomas C ^c   Chaney, Stephen G ^a,d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; OXALIPLATIN;

ARTICLE; CANCER CELL; CANCER RESISTANCE; COLORECTAL CANCER; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DRUG DNA BINDING; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 2; CISPLATIN; COLONIC NEOPLASMS; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENETIC COMPLEMENTATION TEST; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032529467     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fram, R. J., Cusick, P. S., Wilson, J. M., and Marinus, M. G. Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage. Mol. Pharmacol., 28: 51-55, 1985.
2. Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehme, A., Christen, R. D., and Howell, S. B. The role of mismatch repair in platinum drug resistance. Cancer Res., 56: 4881-4886, 1996.
3. Aebi, S., Kurdihaidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., Christen, R. D., Boland, C. R., Koi, M., Fishel, R., and Howell, S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56: 3087-3090, 1996.
4. Fink, D., Zheng, H., Nebel, S., Norris, P. S., Aebi, S., Lin, T-P., Nehme, A., Christen, R. D., Haas, M., MacLeod, C. L., and Howell, S. B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res., 57: 1841-1845, 1997.
5. Drummond, J. T., Anthoney, A., Brown, R., and Modrich, P. Cisplatin and Adriamycin resistance are associated with MutL α and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem., 271: 19645-19648, 1996.
6. Fink, D., Nebel, S., Aebi, S., Nehme, A., and Howell, S. B. Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. Int. J. Oncol., 11: 539-542, 1997.
7. Umar, A., and Kunkel, T. A. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur. J. Biochem., 238: 297-307, 1996.
8. Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem., 272: 24727-24730, 1997.
9. Mellon, I., Rajpal, D. K., Koi, M., Boland, C. R., and Champe, G. N. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science (Washington DC), 272: 557-560, 1996.
10. Karran, P., and Bignami, M. Drug-related killings: a case of mistaken identity. Chem. Biol., 3: 875-879, 1996.
11. Fishel, R., and Wilson, T. MutS homologs in mammalian cells. Curr. Opin. Genet. Dev., 7: 105-113, 1997.
12. Nehme, A., Baskaran, R., Aebi, S., Fink, D., Nebel, S., Cenni, B., Wang, J. Y. J., Howell, S, B., and Christen, R. D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and deficient cells exposed to cisplatin. Cancer Res., 57: 3253-3257, 1997.
13. Umar, A., Buermeyer, A. B., Simon, J. A., Thomas, D. C., Clark, A. B., Liskay, R. M., and Kunkel, T. A. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell, 87: 65-73, 1996.
14. Johnson, R. E., Kovvali, G. K., Guzder, S. N., Amin, N. S., Holm, C., Habraken, Y., Sung, P., Prakash, L., and Prakash, S. Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair. J. Biol. Chem., 271: 27987-27990, 1996.
15. Longley, M. J., Pierce, A. J., and Modrich, P. DNA polymerase δ is required for human mismatch repair in vitro. J. Biol. Chem., 272: 10917-10921, 1997.
16. Anthoney, D. A., McIlwrath, A. J., Gallagher, W. M., Edlin, A. R. M., and Brown, R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res., 56: 1374-1381, 1996.
17. Brown, R., Hirst, G., McIlwrath, A. J., Gallagher, W. M., van der Zee, A., and Anthoney, A. Loss of hMLH1 expression and cisplatin resistance in ovarian tumor cells. Proc. Am. Assoc. Cancer Res., 38: 4, 1997.
18. Brown, R., Hirst, G. L., Gallagher, W. M., McIlwrath, A. J., Margison, G. P., Vanderzee, A. G. J., and Anthoney, D. A. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene, 15: 45-52, 1997.
19. Mu, D., Tursun, M., Duckett, D. R., Drummond, J. T., Modrich, P., and Sancar, A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell. Biol., 17: 760-769, 1997.
20. Duckett, D. R., Drummond, J. T., Murchie, A. I. H., Reardon, J. T., Sancar, A., Lilley, D. M., and Modrich, P. Human MutS α recognizes damaged DNA base pairs containing O-6-methylguanine, O-4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA, 93: 6443-6447, 1996.
21. Mello, J. A., Acharya, S., Fishel, R., and Essigmann, J. M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol., 3: 579-589, 1996.
22. Yamada, M., Oregan, E., Brown, R., and Karran, P. Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucleic Acids Res., 25: 491-495, 1997.
23. Moggs, J. G., Szymkowski, D. E., Yamada, M., Karran, P., and Wood, R. D. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucleic Acids Res., 25: 480-490, 1997.
24. 2 cell cycle checkpoint. Cancer Res., 55: 3721-3725, 1995.
25. Goldmacher, V. S., Cuzick, R. A., and Thilly, W. G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N-nitrosoguanidine. J. Biol, Chem., 261: 12462-12471, 1986.
26. van Bloom, S. S. G. E., Yang, D., Reedijk, J., van der Marel, G. A., and Wang, A. H. J. Structural effect of intra-strand cisplatin crosslink on palindromic DNA sequences. J. Biomol. Struct. Dyn., 13: 989-998, 1996.
27. Parker, R. J., Eastman, A., Bostick-Bruton, F., and Reed, E. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J. Clin. Invest., 87: 772-777, 1991.
28. Johnson, S. W., Ferez, R. P., Godwin, A. K., Yeung, A. T., Handel, L. M., Ozols, R. F., and Hamilton, T. C. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol., 47: 689-697, 1994.
29. Johnson, S. W., Swiggard, P. A., Handel, L. M., Brennan, J. M., Godwin, A. K., Ozols, R. F., and Hamilton, T. C. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res., 54: 5911-5916, 1994.
30. Schmidt, W., and Chaney, S. G. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Res., 53: 799-805, 1993,
31. Mamenta, E. L., Poma, E. E., Kaufmann, W. K., Delmastro, D. A., Grady, H. L., and Chaney, S. G. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res., 54: 3500-3505, 1994.
32. Risinger, J. I., Umar, A., Boyd, J., Berchuk, A., Kunkel, T. A., and Barrett, J. C. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat. Genet., 14: 102-105, 1996.
33. Umar, A., Koi, M., Risinger, J. I., Glaab, W. E., Tindall, K. R., Kolodner, R. D., Boland, C. R., Barrett, J. C., and Kunkel, T. A. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res., 57: 3949-3955, 1997.
34. Boyer, J. C., Umar, A., Risinger, J. I., Lipford, J. R., Kane, M., Yin, S., Barrett, J. C., Kolodner, R. D., and Kunkel, T. A. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res., 55: 6063-6070, 1995.
35. Umar, A., Risinger, J. I., Glaab, W. E., Tindall, K. R., Barrett, J. C., and Kunkel, T. A. Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics, 148: 1637-1646, 1998.
36. da Costa, L. T., Liu, B., El-Diery, W. S., Hamilton, S. R., Kinzler, K. W., Vogelstein, B., Markowitz, S., Willson, J. K. V., de la Chapelle, A., Downey, K. M., and So, A. G. Polymerase δ variants in RER colorectal tumours. Nat. Genet., 9: 10-11, 1995.
37. Gibbons, G, R., Kaufmann, W. K., and Chaney, S. G. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Carcinogenesis (Lond.), 12: 2253-2257, 1991.
38. Kolodner, R. D. Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci., 20: 397-401, 1995.
39. Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J. M., Kunkel, T. A., and Boland, C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res., 54: 4308-4312, 1994.
40. Kaufmann, W. K., and Cleaver, J. E. Mechanisms of inhibition of DNA replication by ultraviolet light in normal human and xeroderma pigmentosum fibroblasts. J. Mol. Biol., 149: 171-187, 1981.
41. Johnson, S. W., Ozols, R. F., and Hamilton, T. C. Mechanisms of drug resistance in ovarian cancer. Cancer (Phila.), 71: 644-649, 1993.
42. Hoffmann, J. S., Pillaire, M. J., Lesca, C., Burnouf, D., Fuchs, R. P. P., Defais, M., and Villani, G. Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates. Proc. Natl. Acad. Sci. USA, 93: 13766-13769, 1996.
43. Kaufmann, W. K. Pathways of human cell post-replication repair. Carcinogenesis (Lond.), 10: 1-11, 1989.